GTCR Invests in Biocoat

1315 Capital Acquires Biocoat, Inc.

January 16, 2019

Medical Devices

Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.

Tidewater Investment Company Acquires Technical Coating International

March 4, 2025

Manufacturing

Wilmington-based Tidewater Investment Company has acquired Technical Coating International Inc. (TCI), a Leland, North Carolina contract coater and laminator, in a transaction completed in February. Tidewater plans to keep TCI’s core leadership in place while appointing operating partner Bill Brinkley as CEO and pursue expansion into new end markets such as food and beverage packaging, military applications, upholstery, and outdoor coverings.

Surmodics Merges with Biocoat; Forms Surmodics Services & Technologies Division

December 10, 2025

Medical Devices

Surmodics has completed a merger with Biocoat and formed a new division, Surmodics Services & Technologies (SST), to carry forward the portion of Biocoat's business remaining after divesting certain assets. SST, based in Horsham, Pennsylvania, will provide hydrophilic coating technologies, custom polymer formulations and full-service coating operations to medical device manufacturers worldwide.

GTCR Invests $1.33 Billion in Tricentis

November 26, 2024

Software

GTCR has signed a definitive agreement to invest $1.33 billion in Tricentis, valuing the enterprise at $4.5 billion. Insight Partners will continue as a significant investor and will work with GTCR with equal board representation as Tricentis uses the capital to fuel growth, product innovation, and global expansion.

GTCR Recapitalizes Cole-Parmer with Golden Gate Capital and Management

September 26, 2019

Medical Devices

GTCR has signed a definitive agreement to recapitalize Cole-Parmer Instrument Company, acquiring a majority stake while Golden Gate Capital and CEO Bernd Brust with the Cole-Parmer management team retain significant minority ownership. The recapitalization will support Cole-Parmer's continued organic growth and strategic M&A in the life sciences, healthcare and environmental laboratory products markets; the company will remain headquartered in Vernon Hills, Illinois.

GTCR Announces $200M Strategic Minority Investment in Solmetex

October 15, 2025

Dental

GTCR has made a structured minority investment of up to $200 million in Solmetex to fund the company's growth initiatives and support near-term add-on acquisitions. GTCR will partner with existing shareholders including AGIC Capital and Solmetex CEO Gene Dorff to scale the company's dental products and consumables business serving more than 85,000 U.S. dental practices.